INTIMATION FOR BODHIKA SEMINAR - 07/3/2022

DEPARTMENT OF PRASOOTI TANTRA AND STREEROGA

GOVT. AYURVEDA COLLEGE, THIRUVANANTHAPURAM

NAME  OF  FIRST PRESENTEE : Dr DEEPA C R 

   

THESIS TOPIC: EFFECT OF MALARINJI MODAKA IN GARBHINI CHARDI

NAME OF GUIDE: DR SHAHINAMOL  S 

DATE: 07/3/2022

TIME: 2:00-4:00 PM

VENUE: MICROSOFT TEAMS

ABSTRACT

Nausea and vomiting is a common experience in pregnancy affecting 70 to 80% of all pregnant women. Altered immunological hormonal and psychological states are responsible for initiation of symptoms include nausea vomiting retching and occasional sickness. Simple vomiting if not properly managed with active antenatal care which may cause hyper emesis gravidarum which in turn cause slow starvation dehydration electrolyte imbalance weight loss and lead to impairment in daily activities of pregnant lady. Anti-emetic and anti-histamines are used in conventional Allopathic practise. In unresponsive cases need hospitalization and even termination of pregnancy. So, there is an intense need of alternative nontoxic safe and economic remedy to manage this condition.

            In Ayurveda all the classical texts mentioned nausea and vomiting are symptoms of normal pregnancy. Acharya Hareetha included garbhini chardi among garbha upadravas which indicates any disorder of garbhini due to foetus. Considering sukha sukumara properties of garbhini, Malarinji modaka can be judiciously given. Malar (laja that is the puffed rice) is the agrya aushadha for chardi and inji (ginger) has proven effect on nausea and vomiting in pregnancy. The study design is a non-randomized control trial. 52 participants below 22 weeks of gestation with PUQE score between 6 and 13 selected from the OPD of Govt. Ayurveda College Hospital For Women and Children Poojappura. Participants are allocated to Group A and Group B. Group A is the trial group in which Malarinji modaka is given to participants, Group B is the control group in which Doxinate (Doxylamine and pyridoxine) is given to participants for treatment. Change in frequency of nausea and vomiting is assessed with PUQE score. Results statistically analysed, summarized and conclusion would be done.

NAME  OF  FIRST PRESENTEE : Dr DRISHYA P T

   

THESIS TOPIC: EFFECT OF KUSHMANDA SWARASA GHRITA IN POSTPARTUM DEPRESSION

NAME OF GUIDE: Dr JYOTHI P K

 

NAME OF CO GUIDE:Dr ANILA M

DATE: 07/3/2022

TIME: 2:00-4:00 PM

VENUE: MICROSOFT TEAMS

ABSTRACT

Pregnancy and child birth produces a variety of physiological, psychological & socialconsequences. Postpartum depression is the major psychiatric illness among them. Prevalence estimates ranges from 13-19% in resource rich setting and 11-42% in resource limited setting. Postpartum depression has a significant impact on the mother-infant relation, in the family and with her partner. The exact cause of postpartum depression is not detected. It may be due to the abrupt change in reproductive hormonal level which rises during pregnancy. Early identification and management of postpartum depression is very essential, otherwise it may lead to a condition of depression even after the period of postpartum. Usually antidepressant medicine and psychiatric counselling are used to treat postpartum depression conventionally, but side   effects of antidepressant medicine badly affect the lactating mother and also the infant. In Ayurveda we can’t see a direct correlation of postpartum depression. Vishada can be correlated with this condition. Kushmanda swarasa gritha is chosen as a trial drug which is described in Apasmara chikitsa by Acharya Vagbada. It is a good Medhya preparation, cost effective and also easily available.  

Study design is pre and post interventional study with sample size 22. Participants of the study are postpartum ladies who are diagnosed with postpartum depression by Edinburgh post natal depression scale selected from the OPD of Prasuthi Tantra and Streeroga, women and children hospital Poojappura Thiruvananthapuram. Participants who satisfy inclusion criteria are selected. Study tool is Edinburg postnatal depression scale, Case Performa and prepared questionnaire. The study period is 18months. Prepared Medicine will be dispensed through OPD in a 200g container and instructions will be given to use daily 24 g of two equal divided doses in empty stomach with hot water as anupana for 30 days. The Edinburgh postnatal depression scale of the participants will be reassessed on 31^st day and compared with previous score.